A NEW POSSIBILITY FOR PHYSIQUE REGULATION?

Researchers are rapidly investigating retatrutide, a promising treatment developed by Eli Lilly, as a potential advance in body management. Unlike many earlier approaches, retatrutide is a double -action agonist targeting simultaneously GLP-1 and GIP, chemicals that affect satiety and glucose reg